In a previous study, we found that SKA1/2/3 was significantly highly expressed in HER2-positive BC (Figure 2(b)), so we further investigated the clinical relevance and prognostic value of SKA1/2/3 among HER2-positive BC patients. The gene discussed is ERBB2; the disease is breast cancer.